$Oragenics (OGEN.US)$ Before conducting a clinical trial, th...

$Oragenics (OGEN.US)$ Before conducting a clinical trial, the FDA requires pharmaceuticals to be tested on cardiac receptors to ensure that they do not show any causes of electrical malformations.Based on Phase 1 ONP-002 clinical trial dosing and subsequent blood plasma concentrations, ONP-002 is expected to have a large cardiac safety margin, suggesting that ONP-002 treatment for concussion will not cause cardiac arrhythmia (irregular heartbeat).